Hepatology - Hepatology Xagena

Hepatology

News

Drugs

Xagena Medicine

Xagena.net

Hepatitis C: treatment with once-weekly Pegasys can achieve viral clearance in patients not responding to Peg-Intron

Hepatitis C infection linked to increased risk of non-Hodgkin lymphoma

Liver transplant recipients with HCV: survival does not improve

Liver stiffness can predict severe portal hypertension

Risk factors for diabetes following liver transplant

Hepatitis C: patients treated with Interferon likely to experience retinopathy

Liver transplant: FDA has approved HepaGam B to prevent hepatitis B reinfection

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis

Non-alcoholic steatohepatitis: ascites is the most common complication of cirrhosis

Intrahepatic cholestasis during pregnancy associated with other liver diseases later in life

Weight loss may improve the efficacy of therapy for hepatitis C

Coffee drinking linked to lower risk for alcohol-related liver disease

Chronic hepatitis in pediatric liver transplant patients

Nonalcoholic fatty liver disease linked to increased risk of heart disease

Liver transplants can be successful in HIV patients with hepatitis B

Lamivudine in order to prevent hepatitis B relapse during chemotherapy

Hepatitis C: serum viral levels recur rapidly after liver transplant

Cyclosporine inhibits hepatitis C virus in vitro

Cholestatic liver damage may be associated with an immune response affecting the central nervous system

Difficulty in treating older hepatitis C patients with Interferon and Ribavirin

Causes of primary biliary cirrhosis

Interferon with Ribavirin is safe and effective for children with chronic hepatitis C

Liver transplant may not be indicated for cystic fibrosis patients with bleeding complication

Increasing incidence of severe Acetaminophen hepatotoxicity

Coffee and tea can reduce the risk of chronic liver disease

Mechanisms leading to portal hypertension identified

Liver transplantation due to Hepatitis C: alpha-SMA, a biomarker, predicts recurrence of disease

High fat diet alters hepatic immune system in mice

Predicting the outcome of drug-induced liver disease

Fulminant hepatic failure, high blood lactate levels may indicate poor prognosis

Next Pages [1] 2

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Drugs

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions